The nationwide online poll, which concluded on Thursday, showed that almost 30% of respondents were very interested in getting the vaccine and another 24% were somewhat interested.
U.S. public health officials earlier this week recommended updated COVID-19 vaccines from Pfizer (PFE.N)/BioNTech (22UAy.DE) and Moderna (MRNA.O) that target a recently circulating Omicron variant of the coronavirus.
Almost 42% said they were mainly interested in getting the vaccine to reduce their risk of severe illness.
During the last revaccination campaign, when most Americas had either already had the COVID virus or been previously vaccinated, only around 56.5 million people got the updated booster shots, CDC data shows.
The Reuters/Ipsos poll was conducted online and nationwide between Sept. 8 and Sept. 14, gathering responses from 4,413 U.S. adults.
Persons:
Adam Berman, Michelle Chester, Ron DeSantis, Jesse Goodman, Ahmed Aboulenein, Jason Lange, Michael Erman, Jennifer Rigby, Scott Malone, Leslie Adler
Organizations:
Jewish Medical Center, Northwell Health, Reuters, U.S . Centers for Disease Control, Pfizer, Moderna, Republicans, Republican, Wednesday, Georgetown University, U.S . Food, Drug Administration, Thomson
Locations:
Long, New Hyde Park , New York, WASHINGTON, United States, ., U.S, Americas, Washington, New York, London